(Q33228129)

24 July 2017

title

The vaccine potential of Streptococcus pneumoniae surface lectin- and non-lectin proteins (English)

1 reference

24 July 2017

main subject

Streptococcus pneumoniae

1 reference

4

Ron Dagan

1 reference

24 July 2017

Yaffa Mizrachi Nebenzahl

series ordinal

5

object named as

Yaffa Mizrachi-Nebenzahl

1 reference

24 July 2017

1

Maxim Portnoi

1 reference

24 July 2017

Eduard Ling

2

1 reference

24 July 2017

Galia Feldman

series ordinal

3

1 reference

24 July 2017

language of work or name

English

0 references

publication date

10 November 2005

1 reference

24 July 2017

1 reference

24 July 2017

volume

24

1 reference

24 July 2017

issue

11

1 reference

24 July 2017

page(s)

1868-1873

1 reference

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Anchorless adhesins and invasins of Gram-positive bacteria: a new class of virulence factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Identification of target tissue glycosphingolipid receptors for uropathogenic, F1C-fimbriated Escherichia coli and its role in mucosal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Isolation, characterization, molecular cloning and molecular modelling of two lectins of different specificities from bluebell (Scilla campanulata) bulbs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Comparison of serum antibodies to pneumolysin with those to pneumococcal capsular polysaccharides in children with acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Cytokine mRNA expression in pneumococcal carriage, pneumonia, and sepsis in young mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

The Escherichia coli G-fimbrial lectin protein participates both in fimbrial biogenesis and in recognition of the receptor N-acetyl-D-glucosamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

N-acetyl-D-galactosamine specific lectin of Eikenella corrodens induces intercellular adhesion molecule-1 (ICAM-1) production by human oral epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Lectin-mediated bacterial adhesion to human tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Initial steps in Streptococcus pneumoniae interaction with and pathogenicity to the host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

alpha-Enolase of Streptococcus pneumoniae is a plasmin(ogen)-binding protein displayed on the bacterial cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Purification of native alpha-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Analysis of expression of a cytosolic enzyme on the surface of Streptococcus pyogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Identification of major outer surface proteins of Streptococcus agalactiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Analysis of Streptococcus mutans proteins modulated by culture under acidic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Effect of acidic pH on expression of surface-associated proteins of Streptococcus oralis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

Mutanolysin-induced spheroplasts of Streptococcus mutants are true protoplasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.10.053

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.10.053

1 reference

24 July 2017

1 reference